The Duke Ophthalmology Neuro-Ophthalmology Division has a long-standing tradition of excellence in basic science, translational, and clinical research. Results from basic science and epidemiological studies are translated into well-designed clinical trials, ultimately leading to the development of new therapies for various neuro-ophthalmic disorders such as optic neuropathies, cranial nerve palsies, nystagmus and others.
Duke Neuro-ophthalmology faculty lead and collaborate with other physician-scientists nationwide in many of the clinical trials that define the evidence base for practice.
The Duke neuro-ophthalmology division has been involved in cutting edge clinical trials:
Idiopathic intracranial hypertension treatment trial,
Quark siRNA intravitreal non-arteritic anterior ischemic optic neuropathy trial
Pediatric optic pathway glioma trial
Pediatric optic neuritis treatment trial
Undiagnosed disease network
Optic nerve and retinal imaging in optic neuropathies
Giant cell arteritis
Leber hereditary optic neuropathy
Ocular motility abnormalities